What Is Amitriptyline?
Amitriptyline is a tricyclic antidepressant (TCA) that's been used for chronic pain since the 1960s. At lower doses than used for depression, it can be effective for neuropathic pain, fibromyalgia, headaches, and other chronic pain conditions. It's one of the most commonly prescribed medications for chronic pain.1
Conditions It Treats2
- Neuropathic pain
- Fibromyalgia
- Migraine prevention
- Tension headache prevention
- Chronic low back pain
- Irritable bowel syndrome
- Insomnia (related to pain)
How It Works
- Increases serotonin and norepinephrine
- Affects pain processing in the brain and spinal cord
- Blocks sodium channels
- Has sedating effects (helps sleep)
- Pain relief independent of antidepressant effect
Dosing for Pain3
- Usually start 10-25 mg at bedtime
- Increase slowly every 1-2 weeks
- Effective dose: 25-75 mg for most
- Lower than depression doses
- Takes 2-4 weeks to work
Common Side Effects
- Drowsiness (often beneficial)
- Dry mouth
- Constipation
- Weight gain
- Blurred vision
- Difficulty urinating
- Morning grogginess
Managing Side Effects
- Take at bedtime (drowsiness)
- Stay hydrated (dry mouth)
- Increase fiber (constipation)
- Start low and go slow
- Side effects often improve with time
Serious Considerations
- Heart rhythm effects (avoid in heart disease)
- Suicidal thoughts (young adults)
- Overdose can be dangerous
- Drug interactions
- Don't stop suddenly—taper
Who Should Avoid
- Recent heart attack
- Certain heart rhythm problems
- Glaucoma (narrow-angle)
- Severe urinary retention
- Taking MAO inhibitors
Effectiveness
- One of most effective for nerve pain
- Number needed to treat: 3-5
- Many benefit at low doses
- Also improves sleep
References
- Moore RA, Derry S, Aldington D, et al. Amitriptyline for neuropathic pain in adults. Cochrane Database Syst Rev. 2015;7:CD008242.
- Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162-173.
- Jackson JL, Shimeall W, Sessums L, et al. Tricyclic antidepressants and headaches: systematic review and meta-analysis. BMJ. 2010;341:c5222.